CRIS Q4 2017 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+38.1% YoY

Gross Profit

$3M94.9% margin

Operating Income

-$7M-218.5% margin

Net Income

-$8M-246.1% margin

EPS (Diluted)

$-5.43

QoQ Revenue Growth

+33.5%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$74M

Total Liabilities

$50M

Stockholders' Equity

$24M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+38.1%
Gross Profit	$3M	$2M	+38.2%
Operating Income	-$7M	-$11M	+33.8%
Net Income	-$8M	-$11M	+29.2%